Clinical Trials Browser

Phase 3 × ADI PEG20 × Clear all

NCT05317819 2025-12-18

Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05712694 2025-07-17

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma

NCT01287585 2019-09-06

ADI-PEG 20

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular